Women who reach menopause should be informed about the risks and symptoms of endometrial cancer, and are strongly encouraged to report any unexpected bleeding or spotting to their physicians. There is no evidence, however, to support endometrial cancer screening for asymptomatic women.
Women with or at risk for HNPCC should be offered screening annually by age 35. And in certain cases, such as women with known genetic abnormalities (Lynch Syndrome), screening with an endometrial biopsy is recommended at yearly intervals during the child bearing years.
In all other cases, women without increased risk should understand the symptoms and contact their doctor if the symptoms occur.